| Pharmaceutical active ingredients: |
| Fluorescein SodiumOxybuprocaine Hydrochloride |
| Available forms, composition and doses of Flu-Oxinate: |
| N / A |
| Flu-Oxinate medical category: |
| Human:DiagnosticsLocal anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01JA51 - Fluorescein, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Akorn |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Minims Lignocaine and Fluoresceine | Fluorescein Sodium; Lidocaine Hydrochloride | Chauvin Pharmaceuticals |
| Fluorox | Fluorescein Sodium; Oxybuprocaine | Medical Ophthalmics |
| Fluorescein; Benoxinate | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Bausch and Lomb |
| Fluoresceine-Oxybuprocaine SDU Faure | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Novartis; OmniVision |
| Fluotest | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Alcon |
| Flurate | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Bausch and Lomb |
| Flurekain | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Croma Pharma |
| Fluress | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Allergan; Abigo Medical; Advanced Medical Optics; Akorn; Pilkington Barnes Hind |
| Flurox | Fluorescein Sodium; Oxybuprocaine Hydrochloride | CYNACON / OCuSOFT |
| Oftan Flurekain | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Santen Pharmaceutical |